Postrenal transplant malignancies in a living-related donor program.
Lal
M
M
Sindh Institute of Urology and Transplantation (SIUT), Dow Medical College and Civil Hospital, Karachi, Pakistan.
Alamdar
S
S
Ali
B
B
Hussain
M
M
Hashmi
A
A
Hussain
Z
Z
Naqvi
A
A
Rizvi
A
A
D000230:Adenocarcinoma / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005190:Family; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation; D019520:Living Donors; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology* / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000628:therapy; D011183:Postoperative Complications / Q000453:epidemiology*; D012189:Retrospective Studies; D012514:Sarcoma, Kaposi / Q000628:therapy; D012878:Skin Neoplasms / Q000628:therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents